Search Orphan Drug Designations and Approvals
-
Generic Name: | aldesleukin |
---|---|
Date Designated: | 07/06/2022 |
Orphan Designation: | Treatment of amyotrophic lateral sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ILTOO Pharma 14 rue des Reculettes Paris, Ile-de-France 75013 France The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-